Year: 2022
Type: review
Abstract: Nonalcoholic fatty liver disease (NAFLD), a spectrum of metabolic liver disease associated with obesity, ranges from relatively benign hepatic steatosis to nonalcoholic steatohepatitis (NASH). The latter is characterized by persistent liver injury, inflammation, and liver fibrosis, which collectively increase the risk for end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. Recent work has shed new light on the pathophysiology of NAFLD/NASH, particularly the role of genetic, epigenetic, and dietary factors and metabolic dysfunctions in other tissues in driving excess hepatic fat accumulation and liver injury. In parallel, single-cell RNA sequencing studies have revealed unprecedented details of the molecular nature of liver cell heterogeneity, intrahepatic cross talk, and disease-associated reprogramming of the liver immune and stromal vascular microenvironment. This review covers the recent advances in these areas, the emerging concepts of NASH pathogenesis, and potential new therapeutic opportunities.
Source: Annual Review of Nutrition
Authors: Liangyou Rui, Jiandie D. Lin
Institutions: University of Michigan, Michigan Medicine
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, hepatic metabolism, liver microenvironment, liver fibrosis, liver inflammation, hepatic steatosis, single-cell RNA sequencing, epigenetic regulation, obesity, liver injury, stromal vascular cells, NASH pathogenesis, NASH therapy
Open Access status: bronze
Awards: Hepatokine Regulation of Thermogenesis and Metabolic Physiology, Role of hepatic Mettl14 pathways in liver metabolism and body metabolic homeostasis, Glucose sensing by skeletal myocytes, The role of hypothalamic Slug in the regulation of leptin sensitivity, energy balance, and body weight, Role of NF-kB-induce kinase (NIK) in liver diseases, Dissecting the NRG4 hormonal checkpoint in metabolic liver disease, Role of adipose mRNA modifications in metabolic disease, Michigan Diabetes Research Center (MDRC)
OpenAlex ID: W4280524965
